Buchumschlag

Providing a Prostate Cancer Detection and Prevention Method With Developed Deep Learning Approach

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Alireza Zarei, Elias Mazrooei Rad, Shahryar Salmani Bajestani, Seyyed Ali Zendehbad
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Prostate Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Determinants of the Cost of Illness in Iranian Prostate Cancer Patients
von: Ramin Ravangard, et al.
Veröffentlicht: (2026)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
von: AhmadReza Rezaeian, et al.
Veröffentlicht: (2026)

The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
von: Pedram Golmohammadi, et al.
Veröffentlicht: (2026)

Development of Mouse‐Tumor Model Using Prostate Cancer (PC3) Cell Line for High‐Intensity Focused Ultrasound (HIFU) Ablation
von: Nabin Khanal, et al.
Veröffentlicht: (2025)

Skeletal Muscle Loss During Treatment With Abiraterone in Patients With Metastatic Prostate Cancer
von: Eva Streckova, et al.
Veröffentlicht: (2025)

Number of Prescription Medications and Overall Survival in Metastatic Castrate‐Resistant Prostate Cancer
von: Carley R. Pickett, et al.
Veröffentlicht: (2024)

Inhibition of Growth and Induction of Apoptosis of Human Prostate Cancer Cells by Enzymatic Blockage of Kallikreins
von: Fabienne Lehner, et al.
Veröffentlicht: (2026)

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance
von: Taku Naiki, et al.
Veröffentlicht: (2025)

MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer
von: Masashi Tsujimoto, et al.
Veröffentlicht: (2025)

Immunohistochemical Detection of CD147 Expression in Adenocarcinoma of the Prostate: A Case‐Control Study
von: Sara Suliman, et al.
Veröffentlicht: (2024)

In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines
von: Ana Laura Gómez-Rosas, et al.
Veröffentlicht: (2026)

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
von: Kazuro Kikkawa, et al.
Veröffentlicht: (2024)

Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS‐CoV‐2 (COVID‐19)
von: Alexander Yaney, et al.
Veröffentlicht: (2026)

Real‐World Treatment Patterns Before and After Metastatic Castration–Resistant Prostate Cancer in Japan: Retrospective Analysis Using a Hospital‐Based, Multicenter Database
von: Masaki Shiota, et al.
Veröffentlicht: (2026)

Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation
von: Dongzhang Li, et al.
Veröffentlicht: (2025)

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
von: Fangming Wang, et al.
Veröffentlicht: (2026)

Autocrine Fibroblast Growth Factor Receptor 1 Signaling Activates Lactate Dehydrogenase A‐Aerobic Glycolysis for Advanced Human Prostate Tumor Growth
von: Xiaoming Xu, et al.
Veröffentlicht: (2025)

Surgical Wait Time Is Not Associated With Oncological or Psychosocial Outcomes After Robotic Radical Prostatectomy
von: Juliette Cotte, et al.
Veröffentlicht: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
von: Reid Vassallo, et al.
Veröffentlicht: (2025)

Perioperative Safety and Early Oncologic Outcomes of Salvage Irreversible Electroporation for Radiorecurrent Prostate Cancer
von: Jarrett Noakes, et al.
Veröffentlicht: (2026)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
von: Elizabeth Robinson, et al.
Veröffentlicht: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
von: Trevor C. Hunt, et al.
Veröffentlicht: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
von: Tatsuya Shimomura, et al.
Veröffentlicht: (2026)

Evidence and Rationale for Prostate Cancer Screening
von: Takeshi Takahashi
Veröffentlicht: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
von: Cameron J. Britton, et al.
Veröffentlicht: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
von: Hannu Koistinen, et al.
Veröffentlicht: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
von: Sheila Jonnatan, et al.
Veröffentlicht: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
von: Andrea K. Miyahira, et al.
Veröffentlicht: (2024)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
von: Yuto Ono, et al.
Veröffentlicht: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
von: Yifu Shi, et al.
Veröffentlicht: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
von: Erum Z. Whyne, et al.
Veröffentlicht: (2025)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
von: Mark Kidd, et al.
Veröffentlicht: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
von: Charly Bâcle, et al.
Veröffentlicht: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
von: Haotian Chen, et al.
Veröffentlicht: (2025)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
von: Toshifumi Takahashi, et al.
Veröffentlicht: (2024)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
von: Christian P. Pavlovich, et al.
Veröffentlicht: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
von: Kristofer G. Taylor, et al.
Veröffentlicht: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
von: Muhammad Umair, et al.
Veröffentlicht: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
von: Christian Andrés Martínez Osorio, et al.
Veröffentlicht: (2025)

Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer
von: Jun Lu, et al.
Veröffentlicht: (2026)